Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

Item
http://www.wikidata.org/entity/Q47699163
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceThe challenge of exploiting ABCG2 in the clinic.Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.ABCG2: the key to chemoresistance in cancer stem cells?The controversial role of ABC transporters in clinical oncology.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.Human ABCG2: structure, function, and its role in multidrug resistance.ABCG2: recent discovery of potent and highly selective inhibitors.Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoP-glycoprotein down-regulates expression of breast cancer resistance protein in a drug-free state.Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.Expression of some ATP-binding cassette transporters in acute myeloid leukemia.Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma.
P2860

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

Item
http://www.wikidata.org/entity/Q47699163
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@en
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@nl
type
label
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@en
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@nl
prefLabel
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@en
Evaluation of BCRP and MDR-1 c ...... ar assessment in AML patients.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Evaluation of BCRP and MDR-1 c ...... lar assessment in AML patients
@en
P2093
P304
P31
P356
10.1016/J.LEUKRES.2003.09.002
P433
P478
P50
P577
P698